CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is September - August.

Year Ending	TTM	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019
Cash & Equivalents	0.07	0.13	0.12	1.39	0.78	0.27
Trading Asset Securities	-	-	-	-	-	3.26
Cash & Short-Term Investments	0.07	0.13	0.12	1.39	0.78	3.52
Cash Growth	66.26%	10.37%	-91.52%	78.30%	-77.92%	152.76%
Receivables	-	-	-	-	-	0.5
Prepaid Expenses	0.01	0.09	0.08	0.2	0.15	0.28
Total Current Assets	0.08	0.22	0.2	1.59	0.93	4.31
Property, Plant & Equipment	-	0.27	0.44	0.64	0.86	1
Long-Term Investments	-	-	0.18	0.85	0.43	6.01
Long-Term Accounts Receivable	-	-	-	-	-	3.86
Total Assets	0.08	0.5	0.81	3.08	2.22	15.18
Accounts Payable	0.19	0.34	0.46	0.18	0.23	0.22
Accrued Expenses	-	0.61	-	-	-	-
Short-Term Debt	1.29	1.34	1.76	0.87	-	-
Other Current Liabilities	1.05	0.22	0.22	0.22	0.22	0.22
Total Current Liabilities	2.53	2.52	2.44	1.27	0.45	0.44
Other Long-Term Liabilities	-	-	0	-	-	-
Total Liabilities	2.53	2.52	2.44	1.27	0.45	0.44
Common Stock	0	0	0	0.01	0.01	0.01
Additional Paid-In Capital	22.44	22.24	18.03	17.06	15.37	15.3
Retained Earnings	-24.89	-24.26	-20.55	-16.83	-13.63	-6.16
Comprensive Income & Other	-	-	0.88	1.55	0.01	5.59
Shareholders' Equity	-2.45	-2.02	-1.63	1.81	1.76	14.74
Total Liabilities & Equity	0.08	0.5	0.81	3.08	2.22	15.18
Total Debt	1.29	1.34	1.76	0.87	-	-
Net Cash (Debt)	-1.22	-1.21	-1.64	0.51	0.78	3.52
Net Cash Growth	-	-	-	-33.83%	-77.92%	152.76%
Net Cash Per Share	-0.04	-0.14	-1.34	0.45	0.69	3.19
Filing Date Shares Outstanding	31.11	28.31	1.26	1.24	1.13	1.12
Total Common Shares Outstanding	31.11	22.61	1.26	1.24	1.13	1.12
Working Capital	-2.45	-2.29	-2.25	0.32	0.48	3.87
Book Value Per Share	-0.08	-0.09	-1.30	1.46	1.57	13.15
Tangible Book Value	-2.45	-2.02	-1.63	1.81	1.76	14.74
Tangible Book Value Per Share	-0.08	-0.09	-1.30	1.46	1.57	13.15

Source: S&P Capital IQ. Standard template.